EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab

Friday 13 Jun, 12:00 PM - 12:00 PM Glasgow, United Kingdom